Managing Partner - Ireland
Simon is one of the industry’s leading Head Hunters in this highly specialised area of Medical Affairs, having spent over 14 years building a global network and deep domain experience that is second to none. He has been with Morgan Prestwich since early 2013, based in Ireland and running our Cork office but travelling throughout Europe and North America.
Simon’s experience also covers Technical Operations including Regulatory Affairs, Quality Assurance and Pharmacovigilance.
Away from the office in Ireland, Simon and his wife Nicola enjoy travelling extensively and experiencing new cultures.
Our clients are focused on leading edge scientific innovation, making Medical and Medical Affairs a pivotal function. Simon Felton, one of the sector’s most knowledgeable and experienced consultants, leads this practice. Simon, together with his team, can build a client’s entire medical function across Europe and North America, from global and above-country senior leadership through to in-country affiliate build out. Our multilingual team of experts work on business-critical projects from Chief Medical Officer recruitment through to building entire teams of MSLs.
Our Technical Operations practice spans Regulatory Affairs, Quality Assurance and Pharmacovigilance.
Each discipline plays a critical role in the safe and effective delivery of medicines to patients, with Regulatory Affairs playing a central role as the interface between the health agencies and various functions within the business. Expertise in the regulatory environment, combined with a strategic overview and the ability to work cross-functionally, makes professionals in this discipline highly sought after. Quality Assurance ensures health providers can be confident that every unit provided reaches the required quality standards and is compliant with all the regulatory standards. Constant monitoring through Pharmacovigilance maintains that confidence over time with constant monitoring used to prevent Adverse Drug Reactions.
Our expert clinical development team support clients from Pre-Clinical through clinical phases I – IV. We strengthen Boards and Leadership teams to develop their science in preparation for commercialisation or acquisition. We work with true start-up Biotech companies in rare, orphan, and speciality diseases, where science can have a real impact on patient lives.
Board, C-suite, Leadership
Great science deserves great teams and great teams need exceptional leadership. This applies right across the whole value chain from Drug Development through to Commercialisation, and getting the right leadership team in place early is a critical success factor. We have an enviable track record of advising and building top Boards and Leadership teams globally, spearheaded by CEO and Founder, Greg Bell, ably supported Sean Morgan-Jones (CCO) and Senior Client Partners Magdalena Meyer, Iman Askari and Emile Hadian.
The Advisory Practice is led by Greg Bell, supported by Sean Morgan-Jones, whose combined experience delivers unique insights into the opportunities and pitfalls associated with building operations beyond the comfort of company Headquarters. They offer practical advice, based on real-world experience on how best to execute this strategy, and ranges from the huge variation in employment contracts – particularly across Europe – to the timing and phasing of any roll-out by functional area.
Our established relationships with key Governmental representatives in the major European centres, help inform decisions on where to best locate European Headquarters in order to take best advantage of both regional incentives and the Biopharma talent pool.
We have strategic partners to support our advisory service right across the full spectrum when launching new products. These partners cover a wide and diverse spectrum including Market Access/Pricing, Regulatory, Medical, Legal, Research, Communications, Governments, Training, HR, Payroll and Investors.